We are live on ! Find out more
CRVO icon

CervoMed

15 hedge funds and large institutions have $2.1M invested in CervoMed in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

50% more capital invested

Capital invested by funds: $1.39M → $2.1M (+$702K)

25% more funds holding

Funds holding: 1215 (+3)

0% less ownership

Funds ownership: 0.01%0.01% (-0%)

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

CRVO Hedge Fund Activity: Q1 2018 in Review

15 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q1 2018, worth a combined $2.1M — up 50% from $1.39M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CRVO positions and 0 closed out — a net gain of 3 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Swift Run Capital Management, adding an estimated $1.4M. The largest seller was Virtu Financial, cutting an estimated $31.2K.

  • 15 institutional investors held CervoMed (CRVO) as of Q1 2018, up from 12 in Q4 2017.
  • Funds reported $2.1M of CervoMed stock for Q1 2018, up 50% quarter-over-quarter.
  • 3 funds opened new CervoMed positions in Q1 2018 and 0 closed out, a net change of +3 holders.
  • The largest CervoMed buyer in Q1 2018 was Swift Run Capital Management, an estimated $1.4M added.
  • The largest CervoMed seller in Q1 2018 was Virtu Financial, an estimated $31.2K sold.

Based on aggregated 13F filings for Q1 2018.